$INCY
Price history, market instrument context, member research, and related headlines in one place.
INCY key statistics
NasdaqGSUSD
52-week range
$84.0257%$132.60
Latest session $108.00–$112.06Incyte Corporation (INCY) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $111.57, up $2.95 (2.72%) from the previous close of $108.62. It has traded between $108.00 and $112.06 in the latest session. Over the past year it has ranged from $84.02 to $132.60, leaving it around the middle of its 52-week range (57%). Reported volume for the session was 1.9M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Incyte forecasts $5.130B-$5.260B 2026 net sales as Opzelura guidance rises to $1.050B-$1.1B after CMS settlement — See source for full details.
Incyte (INCY) beats Q2 estimates and raises 2026 sales guidance as Jakafi, Opzelura and oncology drugs grow; see pipeline catalysts and outlook—read now.
Incyte earnings beat by $1.10, revenue topped estimates — See source for full details.
Incyte Non-GAAP EPS of $3.09 beats by $0.94, revenue of $1.67B beats by $180M — See source for full details.
Incyte Q2 2026 Earnings Preview — See source for full details.
Loading $INCY research…